TY - JOUR
T1 - Gait characteristics in nondisabled community-residing nonagenarians
AU - Krishnamurthy, Mahesh
AU - Verghese, Joe
N1 - Funding Information:
Supported by the National Institutes on Aging (grant nos. AGO3949, RO1 AGO25119) and a Paul B. Beeson Career Development Award (grant no. K23 AG024848).
PY - 2006/4
Y1 - 2006/4
N2 - Objective: To determine gait performance in community-residing nonagenarians. Design: Nested case-control study. Setting: Community. Participants: Thirty-one nondisabled nonagenarians (17 women) and 170 young-old controls (age range, 70-85y) participating in a longitudinal study. Interventions: Not applicable. Main Outcome Measures: Systematic clinical and quantitative gait assessments. We also examined the association of gait velocity with death over a 1-year period. Results: Nonagenarian men had better performance on all quantitative gait parameters examined compared with women. Male sex (β=.58; 95% confidence interval [CI], 9.95-38.89) and depressive symptoms (β=-.34; 95% CI, -6.73 to -0.04) were independently associated with gait velocity in multivariate linear regression models. The 6 hypertensive nonagenarians on angiotensin-converting enzyme (ACE) inhibitors had faster gait velocity (median, 103.1cm/s) compared with the 8 hypertensive nonagenarians not on ACE inhibitors (median, 77.5cm/s; P=.029). Nonagenarians had worse quantitative gait parameters compared with the young-old controls, although the differences were less marked when subjects with clinically normal gaits in both groups were compared. Gait velocity did not predict survival over 1-year follow-up. Conclusions: Gait characteristics in nondisabled community-residing nonagenarians are associated with male sex, depressive symptoms, and medications. The quantitative gait measures in this sample of nondisabled nonagenarians provide a yardstick to compare younger-age groups.
AB - Objective: To determine gait performance in community-residing nonagenarians. Design: Nested case-control study. Setting: Community. Participants: Thirty-one nondisabled nonagenarians (17 women) and 170 young-old controls (age range, 70-85y) participating in a longitudinal study. Interventions: Not applicable. Main Outcome Measures: Systematic clinical and quantitative gait assessments. We also examined the association of gait velocity with death over a 1-year period. Results: Nonagenarian men had better performance on all quantitative gait parameters examined compared with women. Male sex (β=.58; 95% confidence interval [CI], 9.95-38.89) and depressive symptoms (β=-.34; 95% CI, -6.73 to -0.04) were independently associated with gait velocity in multivariate linear regression models. The 6 hypertensive nonagenarians on angiotensin-converting enzyme (ACE) inhibitors had faster gait velocity (median, 103.1cm/s) compared with the 8 hypertensive nonagenarians not on ACE inhibitors (median, 77.5cm/s; P=.029). Nonagenarians had worse quantitative gait parameters compared with the young-old controls, although the differences were less marked when subjects with clinically normal gaits in both groups were compared. Gait velocity did not predict survival over 1-year follow-up. Conclusions: Gait characteristics in nondisabled community-residing nonagenarians are associated with male sex, depressive symptoms, and medications. The quantitative gait measures in this sample of nondisabled nonagenarians provide a yardstick to compare younger-age groups.
KW - Gait
KW - Nonagenarians
KW - Rehabilitation
UR - http://www.scopus.com/inward/record.url?scp=33645347038&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645347038&partnerID=8YFLogxK
U2 - 10.1016/j.apmr.2006.01.006
DO - 10.1016/j.apmr.2006.01.006
M3 - Article
C2 - 16571395
AN - SCOPUS:33645347038
SN - 0003-9993
VL - 87
SP - 541
EP - 545
JO - Archives of Physical Medicine and Rehabilitation
JF - Archives of Physical Medicine and Rehabilitation
IS - 4
ER -